Renal infarction: Difference between revisions

(Created page with "'''Background''' * Major causes: 1. Cardioembolic disease 2. Renal artery injury 3. Hypercoagulable state Category:Nephrology' <ref/Author> Obed KDHCD Barrera")
 
 
(29 intermediate revisions by 8 users not shown)
Line 1: Line 1:
'''Background'''
==Background==
* Major causes:
*Low ED incidence, approximately 1 per 90 to 100, 000 visits a year
1. Cardioembolic disease
*Diagnosis frequently missed due to mimicking symptoms similar to other more frequent complaints such as [[pyelonephritis]] and [[nephrolithiasis]]
2. Renal artery injury
*Caused by interruption of blood supply to kidney
3. Hypercoagulable state


[[Category:Nephrology']]
===Major causes===
<ref/Author>
*Cardioembolic disease
Obed KDHCD Barrera
*Renal artery injury
*[[Hypercoagulable state]]
*[[Dissection]]
*[[Vasculitis]]
 
==Clinical Features==
*[[Flank pain]]
*[[Nausea]], [[vomiting]]
*Sudden onset
 
==Differential Diagnosis==
{{Flank pain DDX}}
 
==Evaluation==
===Laboratory===
*CBC with differential, CMP, LDH, urinalysis, urine culture
* [[EKG]]- to evaluate for arrhythmia 
 
===Imaging<ref>Decoste R, Himmelman JG, Grantmyre J. Acute renal infarct without apparent cause: A case report and review of the literature. Canadian Urological Association Journal. 2015;9(3-4):E237-E239. doi:10.5489/cuaj.2466.</ref>===
*CT with IV contrast (preferred study)
*[[Renal ultrasound]] - less senstive
*MRI with gadolinium (contraindicated with severe renal impairment due to risk of nephrogenic systemic fibrosis)
*Radioisotope scan - not commonly used
 
==Management==
*No clinical guidelines available, but mainstays of therapies include anticoagulation and endovascular therapy
*Endovascular therapy (thrombolysis/thrombectomy/angioplasty)
**Indicated if acute occlusion involving main renal artery or segmental branches
**Greatest likelihood of benefit if performed early
*Anticoagulation:
**IV [[Heparin]] followed by oral [[Coumadin]]
**Indicated in patients with renal infarction in the setting of Atrial fibrillation, LV thrombus, and hyper coagulable state
 
==Disposition==
*Admit
 
==See Also==
 
 
==References==
<references/>
 
[[Category:Renal]]

Latest revision as of 00:38, 27 January 2019

Background

  • Low ED incidence, approximately 1 per 90 to 100, 000 visits a year
  • Diagnosis frequently missed due to mimicking symptoms similar to other more frequent complaints such as pyelonephritis and nephrolithiasis
  • Caused by interruption of blood supply to kidney

Major causes

Clinical Features

Differential Diagnosis

Flank Pain

Evaluation

Laboratory

  • CBC with differential, CMP, LDH, urinalysis, urine culture
  • EKG- to evaluate for arrhythmia

Imaging[1]

  • CT with IV contrast (preferred study)
  • Renal ultrasound - less senstive
  • MRI with gadolinium (contraindicated with severe renal impairment due to risk of nephrogenic systemic fibrosis)
  • Radioisotope scan - not commonly used

Management

  • No clinical guidelines available, but mainstays of therapies include anticoagulation and endovascular therapy
  • Endovascular therapy (thrombolysis/thrombectomy/angioplasty)
    • Indicated if acute occlusion involving main renal artery or segmental branches
    • Greatest likelihood of benefit if performed early
  • Anticoagulation:
    • IV Heparin followed by oral Coumadin
    • Indicated in patients with renal infarction in the setting of Atrial fibrillation, LV thrombus, and hyper coagulable state

Disposition

  • Admit

See Also

References

  1. Decoste R, Himmelman JG, Grantmyre J. Acute renal infarct without apparent cause: A case report and review of the literature. Canadian Urological Association Journal. 2015;9(3-4):E237-E239. doi:10.5489/cuaj.2466.